| Date | Time | Source | Announcement |
|---|---|---|---|
| 15 Mar 2012 | 12:11 PM | Blocklisting Interim Review | |
| 29 Feb 2012 | 01:23 PM | Total Voting Rights | |
| 21 Feb 2012 | 07:00 AM | Half Year Financial Report 2012 | |
| 31 Jan 2012 | 07:00 AM | Product Acquisition HY-50? | |
| 11 Jan 2012 | 07:00 AM | Trading Update | |
| 30 Dec 2011 | 07:00 AM | Total Voting Rights | |
| 22 Dec 2011 | 05:18 PM | Holding(s) in Company | |
| 20 Dec 2011 | 04:05 PM | Holding(s) in Company | |
| 19 Dec 2011 | 04:53 PM | Director/PDMR Shareholding | |
| 15 Dec 2011 | 10:17 AM | Director/PDMR Shareholding | |
| 07 Dec 2011 | 02:49 PM | Director/PDMR Shareholding | |
| 30 Nov 2011 | 04:10 PM | Total Voting Rights | |
| 29 Nov 2011 | 07:00 AM | FDA Approval for Manufacturing at Dales | |
| 04 Nov 2011 | 02:38 PM | Result of AGM | |
| 04 Nov 2011 | 07:00 AM | Interim Management Statement | |
| 31 Oct 2011 | 10:36 AM | Total Voting Rights | |
| 17 Oct 2011 | 04:04 PM | Director/PDMR Shareholding | |
| 14 Oct 2011 | 04:57 PM | Additional Listing - Amendment | |
| 12 Oct 2011 | 05:03 PM | Additional Listing | |
| 30 Sep 2011 | 01:00 PM | Annual Information Update | |
| 30 Sep 2011 | 11:00 AM | Total Voting Rights | |
| 23 Sep 2011 | 09:19 AM | Annual Financial Report | |
| 15 Sep 2011 | 07:00 AM | Blocklisting Interim Review | |
| 07 Sep 2011 | 02:17 PM | Director/PDMR Shareholding | |
| 06 Sep 2011 | 07:00 AM | Final Results | |
| 24 Aug 2011 | 12:26 PM | Holding(s) in Company | |
| 08 Aug 2011 | 07:00 AM | Notice of Results | |
| 28 Jul 2011 | 08:35 AM | Holding(s) in Company | |
| 11 Jul 2011 | 07:00 AM | Trading Update | |
| 01 Jul 2011 | 01:39 PM | Director Declaration | |
| 01 Jul 2011 | 01:17 PM | Director Declaration | |
| 30 Jun 2011 | 10:58 AM | Total Voting Rights | |
| 31 May 2011 | 05:37 PM | Total Voting Rights | |
| 10 May 2011 | 07:00 AM | Interim Management Statement | |
| 28 Apr 2011 | 02:48 PM | Total Voting Rights | |
| 31 Mar 2011 | 12:09 PM | Total Voting Rights | |
| 17 Mar 2011 | 12:47 PM | Blocklisting | |
| 15 Mar 2011 | 02:22 PM | Blocklisting Interim Review | |
| 09 Mar 2011 | 03:48 PM | Holding(s) in Company | |
| 02 Mar 2011 | 03:51 PM | Director/PDMR Shareholding | |
| 01 Mar 2011 | 11:20 AM | Holding(s) in Company | |
| 28 Feb 2011 | 02:00 PM | Total Voting Rights | |
| 25 Feb 2011 | 03:25 PM | Director/PDMR Shareholding | |
| 23 Feb 2011 | 03:57 PM | Director/PDMR Shareholding | |
| 22 Feb 2011 | 07:00 AM | Half Yearly Report | |
| 17 Feb 2011 | 03:18 PM | Director Declaration | |
| 07 Feb 2011 | 03:43 PM | Holding(s) in Company | |
| 02 Feb 2011 | 11:00 AM | Director Declaration | |
| 12 Jan 2011 | 07:00 AM | Pre-Close Period Trading Upda | |
| 31 Dec 2010 | 07:00 AM | Total Voting Rights |
Dechra Pharmaceuticals is a global developer and marketor of eterinary pharmaceuticals and related products.
Based in Northwich, England. It was listed on the London Stock Exchange until it was acquired by EQT AB in January 2024.
Dechra share price was listed under the ticker DPH.